5 Revealing Analyst Questions From Illumina’s Q1 Earnings Call
3 Profitable Stocks We’re Skeptical Of
ILMN Q1 Deep Dive: Clinical Sequencing Fuels Growth as NovaSeq X Demand Surges
Illumina (NASDAQ:ILMN) Posts Better-Than-Expected Sales In Q1 CY2026
SAN DIEGO , April 30, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the first quarter of fiscal year 2026.
Barchart Research What to Expect from ILMN Earnings ILMN Generated April 29, 2026 Current Price $120.37 EPS Estimate $$1.05 Consensus Rating Moderate Buy Average Move 8.41% Illumina's Multiomics Narrative...
Illumina (ILMN) Q1 Earnings Report Preview: What To Look For
Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research
Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care.